WATSON 582 (Propafenone 150 mg)

Pill imprint WATSON 582 has been identified as Propafenone hydrochloride 150 mg.

Propafenone is used in the treatment of atrial fibrillation; ventricular tachycardia; wolff-parkinson-white syndrome; atrial flutter and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 150 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for WATSON 582

Propafenone hydrochloride 150 mg WATSON 582  Front
Propafenone hydrochloride 150 mg WATSON 582  Back
Propafenone hydrochloride
Imprint:
WATSON 582
Strength:
150 mg
Color:
White
Size:
9.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Group I antiarrhythmics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Laboratories, Inc.
National Drug Code (NDC):
00591-0582
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
crospovidone
hypromelloses
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
corn starch
sodium lauryl sulfate
titanium dioxide
triacetin
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68084-0361 Amerisource Health Services
54868-4770 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)